Robert LeBoyer
Stock Analyst at Noble Capital Markets
(0.26)
# 2528
Out of 5,329 analysts
20
Total ratings
31.25%
Success rate
2.32%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
TNXP Tonix Pharmaceutical... | Reiterates: Outperform | 70 70 | 18 | 288.89% | 2 | Mar 20, 2025 | |
NTRB Nutriband | Initiates Coverage On: Outperform | 13 | 6.3 | 106.35% | 1 | Jan 22, 2025 | |
GOVX Geovax Labs | Maintains: Outperform | 6 10 | 0.99 | 910.1% | 2 | Aug 19, 2024 | |
UNCY Unicycive Therapeuti... | Initiates Coverage On: Outperform | 6 | 0.65 | 823.08% | 1 | Feb 14, 2024 | |
CVKD Cadrenal Therapeutic... | Initiates Coverage On: Outperform | 60 | 16.21 | 270.14% | 1 | Dec 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 10 | 3.28 | 204.88% | 1 | Sep 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 14 | 2.5 | 460% | 1 | Feb 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 150 | n/a | n/a | 1 | Oct 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 0.48 | 1566.67% | 2 | Aug 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 120 | 0.65 | 18361.54% | 1 | Jan 25, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Oct 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 9.33 | 28.62% | 1 | Sep 28, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 825000 | n/a | n/a | 1 | Aug 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Apr 10, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 1.66 | 803.61% | 2 | Mar 8, 2018 |